Even though the b-LMB based assay successfully correlated occupancy of XPO1 to dosing level in PBMCs from mice and in cancer cells in culture, it could only measure the drug-target interaction in viable cells, which was not a feasible source of biopsy material from patients [12]. Here, XPO1 is linked to cancer.